DRIVERS IN HTA DECISION-MAKING FOR CHOLESTEROL LOWERING PCSK9 INHIBITORS

被引：0
|
作者：
Kreeftmeijer, J. [1 ]
Dekkers, R. [1 ]
van Engen, A. [1 ]
机构：
[1] Quintiles Advisory Serv, Hoofddorp, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1474
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY157
引用
收藏
页码：A603 / A603
页数：1
相关论文
共 50 条
  • [31] Statins and PCSK9 inhibitors: A new lipid-lowering therapy
    Gallego-Colon, Enrique
    Daum, Aner
    Yosefy, Chaim
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878
  • [32] Lipids and lipid lowering: current management with statins and PCSK9 inhibitors
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2018, 39 (14) : 1117 - 1120
  • [33] A REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS (HTA) OF PCSK9 INHIBITORS (PSCK9I)
    Cork, D.
    Ralston, S.
    Curry, A.
    VALUE IN HEALTH, 2018, 21 : S68 - S68
  • [34] PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Cainzos-Achirica, Miguel
    Martin, Seth S.
    Cornell, John E.
    Murow, Cynthia D.
    Guallar, Eliseo
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (01) : 64 - 65
  • [35] PCSK9 and lipid lowering drugs
    Guo, Yuan-Lin
    Zhang, Wei
    Li, Jian-Jun
    CLINICA CHIMICA ACTA, 2014, 437 : 66 - 71
  • [36] LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy
    Hamasaki, Masato
    Sakane, Naoki
    Hara, Kazuo
    Kotani, Kazuhiko
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (11)
  • [37] Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
    Bandyopadhyay, Dhrubajyoti
    Ashish, Kumar
    Hajra, Adrija
    Qureshi, Arshna
    Ghosh, Raktim K.
    JOURNAL OF LIPIDS, 2018, 2018
  • [38] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [39] Access to PCSK9 Inhibitors
    Baum, Seth J.
    Lepor, Norman E.
    Robinson, Jennifer G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
  • [40] Oral PCSK9 Inhibitors
    Anandita Agarwala
    Ramsha Asim
    Christie M. Ballantyne
    Current Atherosclerosis Reports, 2024, 26 : 147 - 152
12345